Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Our vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.
Our Philosophy
We are long-term thinkers who bet on people, products and quality science.
Investment Scope
biopharmaceuticals, human therapeutics, medical devices, and diagnostics
沪公网安备 31010102005458号